The Infusion Specialty Therapies (IST) business unit of TerSera Therapeutics LLC, which includes two specialty drugs: Quzyttir® (cetirizine hydrochloride injection) and Prialt® (ziconotide intrathecal infusion), was recently completed by ESTEVE with assistance from Arnold & Porter.